compound 5 [PMID: 28038940]   Click here for help

GtoPdb Ligand ID: 9699

PDB Ligand
Compound class: Synthetic organic
Comment: Compound 5 [PMID: 28038940] is a covalent inhibitor of TAK1 kinase (MAP3K7) [2]. It was developed for its potential anti-proliferative activity in cells transformed by the KRAS oncogene.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 85.42
Molecular weight 463.19
XLogP 3.75
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)Nc1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1)N1CCN(CC1)C
Isomeric SMILES C=CC(=O)Nc1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1)N1CCN(CC1)C
InChI InChI=1S/C24H26ClN7O/c1-3-22(33)28-20-6-4-5-7-21(20)29-23-19(25)16-26-24(30-23)27-17-8-10-18(11-9-17)32-14-12-31(2)13-15-32/h3-11,16H,1,12-15H2,2H3,(H,28,33)(H2,26,27,29,30)
InChI Key SCMLGVPMSXTUNC-UHFFFAOYSA-N
References
1. Sakurai H. (2012)
Targeting of TAK1 in inflammatory disorders and cancer.
Trends Pharmacol Sci, 33 (10): 522-30. [PMID:22795313]
2. Tan L, Gurbani D, Weisberg EL, Jones DS, Rao S, Singer WD, Bernard FM, Mowafy S, Jenney A, Du G et al.. (2017)
Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors.
Bioorg Med Chem, 25 (4): 1320-1328. [PMID:28038940]